nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—skin cancer—psoriasis	0.66	1	CtDrD
Temozolomide—CYP3A4—Calcitriol—psoriasis	0.0359	0.191	CbGbCtD
Temozolomide—CYP3A4—Methoxsalen—psoriasis	0.0279	0.149	CbGbCtD
Temozolomide—CYP3A4—Cholecalciferol—psoriasis	0.0185	0.0986	CbGbCtD
Temozolomide—CYP3A4—Mycophenolate mofetil—psoriasis	0.016	0.0855	CbGbCtD
Temozolomide—CYP3A4—Triamcinolone—psoriasis	0.016	0.0855	CbGbCtD
Temozolomide—CYP3A4—Betamethasone—psoriasis	0.0138	0.0733	CbGbCtD
Temozolomide—CYP3A4—Prednisolone—psoriasis	0.0136	0.0724	CbGbCtD
Temozolomide—CYP3A4—Hydrocortisone—psoriasis	0.0129	0.0686	CbGbCtD
Temozolomide—CYP3A4—Prednisone—psoriasis	0.0128	0.0683	CbGbCtD
Temozolomide—CYP3A4—Cyclosporine—psoriasis	0.0121	0.0648	CbGbCtD
Temozolomide—CYP3A4—Dexamethasone—psoriasis	0.008	0.0427	CbGbCtD
Temozolomide—Myalgia—Dexamethasone—psoriasis	4.13e-05	0.000272	CcSEcCtD
Temozolomide—Abdominal pain—Cyclosporine—psoriasis	4.12e-05	0.000271	CcSEcCtD
Temozolomide—Body temperature increased—Cyclosporine—psoriasis	4.12e-05	0.000271	CcSEcCtD
Temozolomide—Anxiety—Betamethasone—psoriasis	4.12e-05	0.000271	CcSEcCtD
Temozolomide—Anxiety—Dexamethasone—psoriasis	4.12e-05	0.000271	CcSEcCtD
Temozolomide—Vomiting—Mycophenolic acid—psoriasis	4.1e-05	0.00027	CcSEcCtD
Temozolomide—Discomfort—Betamethasone—psoriasis	4.08e-05	0.000268	CcSEcCtD
Temozolomide—Discomfort—Dexamethasone—psoriasis	4.08e-05	0.000268	CcSEcCtD
Temozolomide—Dyspepsia—Hydrocortisone—psoriasis	4.08e-05	0.000268	CcSEcCtD
Temozolomide—Haemoglobin—Methotrexate—psoriasis	4.08e-05	0.000268	CcSEcCtD
Temozolomide—Rash—Mycophenolic acid—psoriasis	4.06e-05	0.000267	CcSEcCtD
Temozolomide—Dermatitis—Mycophenolic acid—psoriasis	4.06e-05	0.000267	CcSEcCtD
Temozolomide—Pain—Prednisolone—psoriasis	4.06e-05	0.000267	CcSEcCtD
Temozolomide—Haemorrhage—Methotrexate—psoriasis	4.06e-05	0.000267	CcSEcCtD
Temozolomide—Hepatitis—Methotrexate—psoriasis	4.06e-05	0.000267	CcSEcCtD
Temozolomide—Urticaria—Mycophenolate mofetil—psoriasis	4.04e-05	0.000266	CcSEcCtD
Temozolomide—Headache—Mycophenolic acid—psoriasis	4.04e-05	0.000266	CcSEcCtD
Temozolomide—Decreased appetite—Hydrocortisone—psoriasis	4.03e-05	0.000265	CcSEcCtD
Temozolomide—Pharyngitis—Methotrexate—psoriasis	4.03e-05	0.000265	CcSEcCtD
Temozolomide—Body temperature increased—Mycophenolate mofetil—psoriasis	4.02e-05	0.000265	CcSEcCtD
Temozolomide—Abdominal pain—Mycophenolate mofetil—psoriasis	4.02e-05	0.000265	CcSEcCtD
Temozolomide—Urinary tract disorder—Methotrexate—psoriasis	4.01e-05	0.000264	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Hydrocortisone—psoriasis	4e-05	0.000263	CcSEcCtD
Temozolomide—Fatigue—Hydrocortisone—psoriasis	4e-05	0.000263	CcSEcCtD
Temozolomide—Vision blurred—Prednisone—psoriasis	3.98e-05	0.000262	CcSEcCtD
Temozolomide—Urethral disorder—Methotrexate—psoriasis	3.98e-05	0.000262	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.98e-05	0.000262	CcSEcCtD
Temozolomide—Pain—Hydrocortisone—psoriasis	3.96e-05	0.000261	CcSEcCtD
Temozolomide—Anaphylactic shock—Dexamethasone—psoriasis	3.96e-05	0.00026	CcSEcCtD
Temozolomide—Anaphylactic shock—Betamethasone—psoriasis	3.96e-05	0.00026	CcSEcCtD
Temozolomide—Oedema—Dexamethasone—psoriasis	3.96e-05	0.00026	CcSEcCtD
Temozolomide—Oedema—Betamethasone—psoriasis	3.96e-05	0.00026	CcSEcCtD
Temozolomide—Insomnia—Triamcinolone—psoriasis	3.95e-05	0.00026	CcSEcCtD
Temozolomide—Infection—Betamethasone—psoriasis	3.93e-05	0.000259	CcSEcCtD
Temozolomide—Infection—Dexamethasone—psoriasis	3.93e-05	0.000259	CcSEcCtD
Temozolomide—Ill-defined disorder—Prednisone—psoriasis	3.92e-05	0.000258	CcSEcCtD
Temozolomide—Paraesthesia—Triamcinolone—psoriasis	3.92e-05	0.000258	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisolone—psoriasis	3.91e-05	0.000257	CcSEcCtD
Temozolomide—Visual impairment—Methotrexate—psoriasis	3.91e-05	0.000257	CcSEcCtD
Temozolomide—Anaemia—Prednisone—psoriasis	3.9e-05	0.000257	CcSEcCtD
Temozolomide—Dyspnoea—Triamcinolone—psoriasis	3.89e-05	0.000256	CcSEcCtD
Temozolomide—Nervous system disorder—Dexamethasone—psoriasis	3.88e-05	0.000255	CcSEcCtD
Temozolomide—Nervous system disorder—Betamethasone—psoriasis	3.88e-05	0.000255	CcSEcCtD
Temozolomide—Agitation—Prednisone—psoriasis	3.88e-05	0.000255	CcSEcCtD
Temozolomide—Thrombocytopenia—Betamethasone—psoriasis	3.88e-05	0.000255	CcSEcCtD
Temozolomide—Thrombocytopenia—Dexamethasone—psoriasis	3.88e-05	0.000255	CcSEcCtD
Temozolomide—Angioedema—Prednisone—psoriasis	3.86e-05	0.000254	CcSEcCtD
Temozolomide—Hypersensitivity—Cyclosporine—psoriasis	3.84e-05	0.000253	CcSEcCtD
Temozolomide—Dyspepsia—Triamcinolone—psoriasis	3.84e-05	0.000253	CcSEcCtD
Temozolomide—Erythema multiforme—Methotrexate—psoriasis	3.83e-05	0.000252	CcSEcCtD
Temozolomide—Nausea—Mycophenolic acid—psoriasis	3.83e-05	0.000252	CcSEcCtD
Temozolomide—Hyperhidrosis—Betamethasone—psoriasis	3.83e-05	0.000252	CcSEcCtD
Temozolomide—Hyperhidrosis—Dexamethasone—psoriasis	3.83e-05	0.000252	CcSEcCtD
Temozolomide—Feeling abnormal—Hydrocortisone—psoriasis	3.82e-05	0.000251	CcSEcCtD
Temozolomide—Malaise—Prednisone—psoriasis	3.81e-05	0.000251	CcSEcCtD
Temozolomide—Vertigo—Prednisone—psoriasis	3.8e-05	0.00025	CcSEcCtD
Temozolomide—Eye disorder—Methotrexate—psoriasis	3.79e-05	0.000249	CcSEcCtD
Temozolomide—Gastrointestinal pain—Hydrocortisone—psoriasis	3.79e-05	0.000249	CcSEcCtD
Temozolomide—Tinnitus—Methotrexate—psoriasis	3.78e-05	0.000249	CcSEcCtD
Temozolomide—Anorexia—Betamethasone—psoriasis	3.77e-05	0.000248	CcSEcCtD
Temozolomide—Anorexia—Dexamethasone—psoriasis	3.77e-05	0.000248	CcSEcCtD
Temozolomide—Urticaria—Prednisolone—psoriasis	3.77e-05	0.000248	CcSEcCtD
Temozolomide—Cardiac disorder—Methotrexate—psoriasis	3.76e-05	0.000248	CcSEcCtD
Temozolomide—Fatigue—Triamcinolone—psoriasis	3.76e-05	0.000248	CcSEcCtD
Temozolomide—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.75e-05	0.000247	CcSEcCtD
Temozolomide—Asthenia—Cyclosporine—psoriasis	3.74e-05	0.000246	CcSEcCtD
Temozolomide—Pain—Triamcinolone—psoriasis	3.73e-05	0.000245	CcSEcCtD
Temozolomide—Pruritus—Cyclosporine—psoriasis	3.69e-05	0.000243	CcSEcCtD
Temozolomide—Urticaria—Hydrocortisone—psoriasis	3.68e-05	0.000242	CcSEcCtD
Temozolomide—Angiopathy—Methotrexate—psoriasis	3.68e-05	0.000242	CcSEcCtD
Temozolomide—Immune system disorder—Methotrexate—psoriasis	3.66e-05	0.000241	CcSEcCtD
Temozolomide—Abdominal pain—Hydrocortisone—psoriasis	3.66e-05	0.000241	CcSEcCtD
Temozolomide—Body temperature increased—Hydrocortisone—psoriasis	3.66e-05	0.000241	CcSEcCtD
Temozolomide—Convulsion—Prednisone—psoriasis	3.66e-05	0.000241	CcSEcCtD
Temozolomide—Mediastinal disorder—Methotrexate—psoriasis	3.66e-05	0.00024	CcSEcCtD
Temozolomide—Asthenia—Mycophenolate mofetil—psoriasis	3.65e-05	0.00024	CcSEcCtD
Temozolomide—Hypertension—Prednisone—psoriasis	3.65e-05	0.00024	CcSEcCtD
Temozolomide—Chills—Methotrexate—psoriasis	3.64e-05	0.000239	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.61e-05	0.000237	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Betamethasone—psoriasis	3.61e-05	0.000237	CcSEcCtD
Temozolomide—Pruritus—Mycophenolate mofetil—psoriasis	3.6e-05	0.000237	CcSEcCtD
Temozolomide—Myalgia—Prednisone—psoriasis	3.6e-05	0.000237	CcSEcCtD
Temozolomide—Arthralgia—Prednisone—psoriasis	3.6e-05	0.000237	CcSEcCtD
Temozolomide—Feeling abnormal—Triamcinolone—psoriasis	3.6e-05	0.000237	CcSEcCtD
Temozolomide—Anxiety—Prednisone—psoriasis	3.58e-05	0.000236	CcSEcCtD
Temozolomide—Alopecia—Methotrexate—psoriasis	3.58e-05	0.000236	CcSEcCtD
Temozolomide—Insomnia—Dexamethasone—psoriasis	3.58e-05	0.000236	CcSEcCtD
Temozolomide—Insomnia—Betamethasone—psoriasis	3.58e-05	0.000236	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.57e-05	0.000235	CcSEcCtD
Temozolomide—Diarrhoea—Cyclosporine—psoriasis	3.57e-05	0.000235	CcSEcCtD
Temozolomide—Paraesthesia—Dexamethasone—psoriasis	3.56e-05	0.000234	CcSEcCtD
Temozolomide—Paraesthesia—Betamethasone—psoriasis	3.56e-05	0.000234	CcSEcCtD
Temozolomide—Discomfort—Prednisone—psoriasis	3.55e-05	0.000234	CcSEcCtD
Temozolomide—Mental disorder—Methotrexate—psoriasis	3.55e-05	0.000234	CcSEcCtD
Temozolomide—Erythema—Methotrexate—psoriasis	3.53e-05	0.000232	CcSEcCtD
Temozolomide—Malnutrition—Methotrexate—psoriasis	3.53e-05	0.000232	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisolone—psoriasis	3.5e-05	0.00023	CcSEcCtD
Temozolomide—Dyspepsia—Betamethasone—psoriasis	3.49e-05	0.000229	CcSEcCtD
Temozolomide—Dyspepsia—Dexamethasone—psoriasis	3.49e-05	0.000229	CcSEcCtD
Temozolomide—Diarrhoea—Mycophenolate mofetil—psoriasis	3.48e-05	0.000229	CcSEcCtD
Temozolomide—Urticaria—Triamcinolone—psoriasis	3.47e-05	0.000228	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—psoriasis	3.46e-05	0.000227	CcSEcCtD
Temozolomide—Body temperature increased—Triamcinolone—psoriasis	3.45e-05	0.000227	CcSEcCtD
Temozolomide—Dizziness—Cyclosporine—psoriasis	3.45e-05	0.000227	CcSEcCtD
Temozolomide—Oedema—Prednisone—psoriasis	3.45e-05	0.000227	CcSEcCtD
Temozolomide—Anaphylactic shock—Prednisone—psoriasis	3.45e-05	0.000227	CcSEcCtD
Temozolomide—Decreased appetite—Dexamethasone—psoriasis	3.44e-05	0.000226	CcSEcCtD
Temozolomide—Decreased appetite—Betamethasone—psoriasis	3.44e-05	0.000226	CcSEcCtD
Temozolomide—Infection—Prednisone—psoriasis	3.43e-05	0.000225	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Betamethasone—psoriasis	3.42e-05	0.000225	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Dexamethasone—psoriasis	3.42e-05	0.000225	CcSEcCtD
Temozolomide—Back pain—Methotrexate—psoriasis	3.42e-05	0.000225	CcSEcCtD
Temozolomide—Hypersensitivity—Hydrocortisone—psoriasis	3.41e-05	0.000225	CcSEcCtD
Temozolomide—Fatigue—Dexamethasone—psoriasis	3.41e-05	0.000225	CcSEcCtD
Temozolomide—Fatigue—Betamethasone—psoriasis	3.41e-05	0.000225	CcSEcCtD
Temozolomide—Pain—Betamethasone—psoriasis	3.39e-05	0.000223	CcSEcCtD
Temozolomide—Pain—Dexamethasone—psoriasis	3.39e-05	0.000223	CcSEcCtD
Temozolomide—Nervous system disorder—Prednisone—psoriasis	3.38e-05	0.000222	CcSEcCtD
Temozolomide—Dizziness—Mycophenolate mofetil—psoriasis	3.36e-05	0.000221	CcSEcCtD
Temozolomide—Skin disorder—Prednisone—psoriasis	3.35e-05	0.00022	CcSEcCtD
Temozolomide—Hyperhidrosis—Prednisone—psoriasis	3.33e-05	0.000219	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—psoriasis	3.33e-05	0.000219	CcSEcCtD
Temozolomide—Asthenia—Hydrocortisone—psoriasis	3.32e-05	0.000219	CcSEcCtD
Temozolomide—Vomiting—Cyclosporine—psoriasis	3.32e-05	0.000218	CcSEcCtD
Temozolomide—Rash—Cyclosporine—psoriasis	3.29e-05	0.000216	CcSEcCtD
Temozolomide—Anorexia—Prednisone—psoriasis	3.29e-05	0.000216	CcSEcCtD
Temozolomide—Dermatitis—Cyclosporine—psoriasis	3.28e-05	0.000216	CcSEcCtD
Temozolomide—Pruritus—Hydrocortisone—psoriasis	3.28e-05	0.000216	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—psoriasis	3.28e-05	0.000216	CcSEcCtD
Temozolomide—Headache—Cyclosporine—psoriasis	3.27e-05	0.000215	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—psoriasis	3.26e-05	0.000215	CcSEcCtD
Temozolomide—Feeling abnormal—Betamethasone—psoriasis	3.26e-05	0.000215	CcSEcCtD
Temozolomide—Feeling abnormal—Dexamethasone—psoriasis	3.26e-05	0.000215	CcSEcCtD
Temozolomide—Gastrointestinal pain—Dexamethasone—psoriasis	3.24e-05	0.000213	CcSEcCtD
Temozolomide—Gastrointestinal pain—Betamethasone—psoriasis	3.24e-05	0.000213	CcSEcCtD
Temozolomide—Vomiting—Mycophenolate mofetil—psoriasis	3.23e-05	0.000213	CcSEcCtD
Temozolomide—Hypersensitivity—Triamcinolone—psoriasis	3.21e-05	0.000212	CcSEcCtD
Temozolomide—Rash—Mycophenolate mofetil—psoriasis	3.21e-05	0.000211	CcSEcCtD
Temozolomide—Dermatitis—Mycophenolate mofetil—psoriasis	3.2e-05	0.000211	CcSEcCtD
Temozolomide—Headache—Mycophenolate mofetil—psoriasis	3.19e-05	0.00021	CcSEcCtD
Temozolomide—Malaise—Methotrexate—psoriasis	3.18e-05	0.000209	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—psoriasis	3.17e-05	0.000209	CcSEcCtD
Temozolomide—Diarrhoea—Hydrocortisone—psoriasis	3.17e-05	0.000209	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—psoriasis	3.16e-05	0.000208	CcSEcCtD
Temozolomide—Urticaria—Dexamethasone—psoriasis	3.15e-05	0.000207	CcSEcCtD
Temozolomide—Urticaria—Betamethasone—psoriasis	3.15e-05	0.000207	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Prednisone—psoriasis	3.14e-05	0.000207	CcSEcCtD
Temozolomide—Dizziness—Prednisolone—psoriasis	3.14e-05	0.000206	CcSEcCtD
Temozolomide—Asthenia—Triamcinolone—psoriasis	3.13e-05	0.000206	CcSEcCtD
Temozolomide—Abdominal pain—Betamethasone—psoriasis	3.13e-05	0.000206	CcSEcCtD
Temozolomide—Body temperature increased—Betamethasone—psoriasis	3.13e-05	0.000206	CcSEcCtD
Temozolomide—Abdominal pain—Dexamethasone—psoriasis	3.13e-05	0.000206	CcSEcCtD
Temozolomide—Body temperature increased—Dexamethasone—psoriasis	3.13e-05	0.000206	CcSEcCtD
Temozolomide—Insomnia—Prednisone—psoriasis	3.12e-05	0.000205	CcSEcCtD
Temozolomide—Nausea—Cyclosporine—psoriasis	3.1e-05	0.000204	CcSEcCtD
Temozolomide—Paraesthesia—Prednisone—psoriasis	3.1e-05	0.000204	CcSEcCtD
Temozolomide—Pruritus—Triamcinolone—psoriasis	3.09e-05	0.000203	CcSEcCtD
Temozolomide—Cough—Methotrexate—psoriasis	3.08e-05	0.000203	CcSEcCtD
Temozolomide—Dizziness—Hydrocortisone—psoriasis	3.06e-05	0.000202	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—psoriasis	3.06e-05	0.000201	CcSEcCtD
Temozolomide—Dyspepsia—Prednisone—psoriasis	3.04e-05	0.0002	CcSEcCtD
Temozolomide—Nausea—Mycophenolate mofetil—psoriasis	3.02e-05	0.000199	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—psoriasis	3.01e-05	0.000198	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—psoriasis	3.01e-05	0.000198	CcSEcCtD
Temozolomide—Decreased appetite—Prednisone—psoriasis	3e-05	0.000197	CcSEcCtD
Temozolomide—Rash—Prednisolone—psoriasis	2.99e-05	0.000197	CcSEcCtD
Temozolomide—Dermatitis—Prednisolone—psoriasis	2.99e-05	0.000197	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.99e-05	0.000196	CcSEcCtD
Temozolomide—Fatigue—Prednisone—psoriasis	2.97e-05	0.000196	CcSEcCtD
Temozolomide—Headache—Prednisolone—psoriasis	2.97e-05	0.000196	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—psoriasis	2.97e-05	0.000195	CcSEcCtD
Temozolomide—Constipation—Prednisone—psoriasis	2.95e-05	0.000194	CcSEcCtD
Temozolomide—Vomiting—Hydrocortisone—psoriasis	2.95e-05	0.000194	CcSEcCtD
Temozolomide—Rash—Hydrocortisone—psoriasis	2.92e-05	0.000192	CcSEcCtD
Temozolomide—Dermatitis—Hydrocortisone—psoriasis	2.92e-05	0.000192	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—psoriasis	2.91e-05	0.000191	CcSEcCtD
Temozolomide—Headache—Hydrocortisone—psoriasis	2.9e-05	0.000191	CcSEcCtD
Temozolomide—Dizziness—Triamcinolone—psoriasis	2.89e-05	0.00019	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—psoriasis	2.88e-05	0.00019	CcSEcCtD
Temozolomide—Infection—Methotrexate—psoriasis	2.86e-05	0.000188	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisone—psoriasis	2.84e-05	0.000187	CcSEcCtD
Temozolomide—Asthenia—Betamethasone—psoriasis	2.84e-05	0.000187	CcSEcCtD
Temozolomide—Asthenia—Dexamethasone—psoriasis	2.84e-05	0.000187	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—psoriasis	2.83e-05	0.000186	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—psoriasis	2.82e-05	0.000186	CcSEcCtD
Temozolomide—Gastrointestinal pain—Prednisone—psoriasis	2.82e-05	0.000185	CcSEcCtD
Temozolomide—Nausea—Prednisolone—psoriasis	2.82e-05	0.000185	CcSEcCtD
Temozolomide—Pruritus—Dexamethasone—psoriasis	2.8e-05	0.000184	CcSEcCtD
Temozolomide—Pruritus—Betamethasone—psoriasis	2.8e-05	0.000184	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—psoriasis	2.8e-05	0.000184	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—psoriasis	2.79e-05	0.000183	CcSEcCtD
Temozolomide—Vomiting—Triamcinolone—psoriasis	2.77e-05	0.000183	CcSEcCtD
Temozolomide—Nausea—Hydrocortisone—psoriasis	2.75e-05	0.000181	CcSEcCtD
Temozolomide—Rash—Triamcinolone—psoriasis	2.75e-05	0.000181	CcSEcCtD
Temozolomide—Dermatitis—Triamcinolone—psoriasis	2.75e-05	0.000181	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—psoriasis	2.75e-05	0.000181	CcSEcCtD
Temozolomide—Urticaria—Prednisone—psoriasis	2.74e-05	0.00018	CcSEcCtD
Temozolomide—Headache—Triamcinolone—psoriasis	2.73e-05	0.00018	CcSEcCtD
Temozolomide—Body temperature increased—Prednisone—psoriasis	2.73e-05	0.000179	CcSEcCtD
Temozolomide—Abdominal pain—Prednisone—psoriasis	2.73e-05	0.000179	CcSEcCtD
Temozolomide—Diarrhoea—Betamethasone—psoriasis	2.71e-05	0.000178	CcSEcCtD
Temozolomide—Diarrhoea—Dexamethasone—psoriasis	2.71e-05	0.000178	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—psoriasis	2.63e-05	0.000173	CcSEcCtD
Temozolomide—Dizziness—Dexamethasone—psoriasis	2.62e-05	0.000172	CcSEcCtD
Temozolomide—Dizziness—Betamethasone—psoriasis	2.62e-05	0.000172	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—psoriasis	2.61e-05	0.000171	CcSEcCtD
Temozolomide—Nausea—Triamcinolone—psoriasis	2.59e-05	0.000171	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—psoriasis	2.59e-05	0.00017	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—psoriasis	2.57e-05	0.000169	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—psoriasis	2.56e-05	0.000169	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisone—psoriasis	2.54e-05	0.000167	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—psoriasis	2.54e-05	0.000167	CcSEcCtD
Temozolomide—Vomiting—Betamethasone—psoriasis	2.52e-05	0.000166	CcSEcCtD
Temozolomide—Vomiting—Dexamethasone—psoriasis	2.52e-05	0.000166	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—psoriasis	2.5e-05	0.000165	CcSEcCtD
Temozolomide—Rash—Betamethasone—psoriasis	2.5e-05	0.000164	CcSEcCtD
Temozolomide—Rash—Dexamethasone—psoriasis	2.5e-05	0.000164	CcSEcCtD
Temozolomide—Dermatitis—Betamethasone—psoriasis	2.49e-05	0.000164	CcSEcCtD
Temozolomide—Dermatitis—Dexamethasone—psoriasis	2.49e-05	0.000164	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—psoriasis	2.49e-05	0.000164	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—psoriasis	2.48e-05	0.000163	CcSEcCtD
Temozolomide—Headache—Betamethasone—psoriasis	2.48e-05	0.000163	CcSEcCtD
Temozolomide—Headache—Dexamethasone—psoriasis	2.48e-05	0.000163	CcSEcCtD
Temozolomide—Asthenia—Prednisone—psoriasis	2.47e-05	0.000163	CcSEcCtD
Temozolomide—Pain—Methotrexate—psoriasis	2.46e-05	0.000162	CcSEcCtD
Temozolomide—Pruritus—Prednisone—psoriasis	2.44e-05	0.00016	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—psoriasis	2.37e-05	0.000156	CcSEcCtD
Temozolomide—Diarrhoea—Prednisone—psoriasis	2.36e-05	0.000155	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—psoriasis	2.36e-05	0.000155	CcSEcCtD
Temozolomide—Nausea—Betamethasone—psoriasis	2.35e-05	0.000155	CcSEcCtD
Temozolomide—Nausea—Dexamethasone—psoriasis	2.35e-05	0.000155	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—psoriasis	2.29e-05	0.000151	CcSEcCtD
Temozolomide—Dizziness—Prednisone—psoriasis	2.28e-05	0.00015	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—psoriasis	2.28e-05	0.00015	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—psoriasis	2.28e-05	0.00015	CcSEcCtD
Temozolomide—Vomiting—Prednisone—psoriasis	2.19e-05	0.000144	CcSEcCtD
Temozolomide—Rash—Prednisone—psoriasis	2.17e-05	0.000143	CcSEcCtD
Temozolomide—Dermatitis—Prednisone—psoriasis	2.17e-05	0.000143	CcSEcCtD
Temozolomide—Headache—Prednisone—psoriasis	2.16e-05	0.000142	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—psoriasis	2.12e-05	0.00014	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—psoriasis	2.07e-05	0.000136	CcSEcCtD
Temozolomide—Nausea—Prednisone—psoriasis	2.05e-05	0.000135	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—psoriasis	2.04e-05	0.000134	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—psoriasis	1.97e-05	0.00013	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—psoriasis	1.91e-05	0.000125	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—psoriasis	1.83e-05	0.000121	CcSEcCtD
Temozolomide—Rash—Methotrexate—psoriasis	1.82e-05	0.00012	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—psoriasis	1.82e-05	0.000119	CcSEcCtD
Temozolomide—Headache—Methotrexate—psoriasis	1.81e-05	0.000119	CcSEcCtD
Temozolomide—Nausea—Methotrexate—psoriasis	1.71e-05	0.000113	CcSEcCtD
